Given all that has happened since that research report estimating the fair value of the company to be at 32 to 34 cents, I find it frankly absurd that we are currently sitting on 13 cents.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025